medline.ch Onkologie Gynäkologische Tumoren

	Evaluation of breast cancer coding quality and its influence on diagnosis-related groupings: a cross-sectional study. Int J Qual Health Care Feng L, Sun R, Zou Y. PMID: 41968071 [PubMed - as supplied by publisher]
	Response to correspondence on "Survival in advanced-staged ovarian cancer treated without cytoreductive surgery: a systematic review and exploratory meta-analysis" by Garkhail et al. Int J Gynecol Cancer Garkhail P, Boere IA, van Beekhuizen HJ, Nieuwenhuyzen-de Boer GM. PMID: 41968028 [PubMed - as supplied by publisher]
	Incidence and impact of low-volume lymph node metastasis in apparent early-stage ovarian cancer: MICR-OVARY study. Int J Gynecol Cancer Bizzarri N, Lago V, Agusti N, Uccella S, Buda A, Torrent A, Perrone AM, Calderaro-Di Ruggiero F, Sadeghi R, Taskiran C, Lambrechts S, Cosentino F, Vizzielli G, Giannarelli D, Di Berardino S, Nero C, Domingo S, Díaz-Feijoo B, Fagotti A. PMID: 41968027 [PubMed - as supplied by publisher]
	The rise of bispecific T-cell engager (BsTCE) antibodies: A potentially game-changing approach for breast cancer therapy? Drug Discov Today Gudavalekar PU, Khandave PY, Shalini S, Selvaraju S, Pande AH. PMID: 41967765 [PubMed - as supplied by publisher]
	Pre-Diagnosis and Post-Treatment Exposures to PM(1), PM(2.5), and PM(10) and Breast Cancer Survival: A Cohort Study. Environ Res Jia Y, Wang C, Tao Y, Wang Y, Yu L, Hu L, Liu G. PMID: 41967747 [PubMed - as supplied by publisher]
	Impact of endometriosis on survival outcomes in ovarian cancer patients: a pilot study. Eur J Obstet Gynecol Reprod Biol Spagnolo E, Hernández MR, Ferreras ER, Guntiñas A, Almellones P, Siegrist J, Carrasco AL, Redondo A, Villagrá I, González AC, Tomás Ferrer R, Céspedes C, Hernández A. PMID: 41967157 [PubMed - as supplied by publisher]
	Sexual distress changes and correlates among breast cancer survivors: a prospective study. J Sex Med Baziliansky S, Sowan W. PMID: 41967064 [PubMed - in process]
	Management of non-detection of the sentinel node in breast cancer: A scoping review. Eur J Surg Oncol Andersen LS, Jensen K, Tvedskov THF. PMID: 41966790 [PubMed - as supplied by publisher]
	Mastitis as a risk factor for breast cancer: a systematic review and meta-analysis. Clin Transl Oncol de Figueiredo Azevedo AC, da Silva RM, de Paiva FA, Rego LHRM, de Moraes FCA. PMID: 41966678 [PubMed - as supplied by publisher]
	Photodynamic Diagnosis Using 5-Aminolevulinic Acid for Detecting Residual Ovarian Cancer within Post-Chemotherapy Scarring: A Case Report. Photodiagnosis Photodyn Ther Nakamoto K, Matoba Y, Uyama T, Tomono K, Teraoka Y, Oomori Y, Yamazaki T, Banno K, Yamaguchi K. PMID: 41966508 [PubMed - as supplied by publisher]
	Religion, Politics, and Vaccines: Elaborating the Integrative Public Policy Acceptance (IPAC) Framework Through HPV Vaccine Program Acceptance Among Religious Leaders in Bangladesh. Int J Health Policy Manag Rahman MT, Mahmood S, Attwell K. PMID: 41966219 [PubMed - indexed for MEDLINE]
	A prospective single-arm pilot study evaluating [F-18]fluoroestradiol dedicated breast PET in invasive lobular carcinoma after neoadjuvant endocrine therapy. Breast Cancer Res Switalla KM, Onishi N, Jones EF, Lawhn-Heath C, Ray KM, Hathi DK, Carmona-Bozo JC, Metanat P, Lopes AJ, Falade IO, Quirarte A, Gottipati S, Guo R, Molina-Vega J, Pullakhandam K, Bareng TJ, Watkins M, Chien AJ, Joe BN, Esserman LJ, Hylton N, Mukhtar RA. PMID: 41965734 [PubMed - as supplied by publisher]
	Patient-reported outcomes of adjuvant therapy with CDK4/6 inhibitors for HR+/HER2- early breast cancer: a retrospective cohort study. BMC Cancer Cong B, Hou C, Shan C, Sun S, Sun S, Xia C, Wang Y. PMID: 41965632 [PubMed - as supplied by publisher]
	Serum 25-hydroxyvitamin D levels among women newly diagnosed with breast cancer at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. BMC Womens Health Meles M, Gutema G, Tsegaye M, Bashea C, Challa F, Bikila D, Gebremicael G, Getahun T, Habtu W, Alem M, Edao A, Carobene A, Tola HH. PMID: 41965576 [PubMed - as supplied by publisher]
	MRI-Based Habitat Analysis for Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study. J Magn Reson Imaging Zhu H, Zhang B, Peng D, Song S, Huang L, Zhang Y, Wu X. PMID: 41965129 [PubMed - as supplied by publisher]
	Editorial for "MRI-Based Habitat Analysis for Assessment of Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study". J Magn Reson Imaging Huang Y, Ren H. PMID: 41965128 [PubMed - as supplied by publisher]
	Selected Pathological Criteria That Predict Low Rates of Axillary Lymph Node Metastases Regardless of Patient Age: A Single Institution Study. Breast J Nathanson SD, Leonard-Murali S, Bui J, Chitale DA, Bensenhaver J, Schwartz T, Petersen L, Springer K, Baker P, Susick LL. PMID: 41964933 [PubMed - indexed for MEDLINE]
	The Predictive Value of the Tumor-Stroma Ratio for Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer. Int J Cancer Andour L, Hagenaars SC, de Groot AF, Krol-Warmerdam EMM, Kroep JR, Hazelbag HM, Liefers GJ, Straver ME, Mesker WE. PMID: 41964157 [PubMed - as supplied by publisher]
	The role of small extracellular vesicles in ovarian cancer drug resistance: from bench clues to clinical implications. J Ovarian Res Chen J, Gu Z, Hua K, Zhang Y, Shen F, Zhang M, Zhou G, Ding J. PMID: 41964086 [PubMed - as supplied by publisher]
	Recent Advances in Surface-Engineered Polymeric Nanoparticles for Targeted Paclitaxel Delivery in Breast Cancer Therapy. AAPS PharmSciTech Fatima M, AlQahtani F, Kesharwani P. PMID: 41963751 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 327218

Seite 1 von 16361

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung